All Series A Warrants exercised by holders as of June 11, 2024

Sunshine Biopharma Inc.

Series A Warrants issued on Feb 15, 2024 fully exercised as of June 11, 2024.
No details on number of warrants, exercise price, or total proceeds provided.
Exercise may result in dilution but share count impact not disclosed.
Company did not specify use of proceeds from the warrant exercises.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.